OrthoPediatrics Corp. launches platform for pediatric nailing | Shin
WARSAW, Ind., October 19, 2023 (GLOBE NEWSWIRE) — Orthopediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company focused solely on advancing the field of pediatric orthopedics, today announced that it has released the new Pediatric Nailing Platform TIBIA System and has successfully completed the first cases of the limited launch has completed. The company received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the system in September 2023.
PNP Tibia is part of the Trauma & Deformity Correction product range and represents another pediatric-focused solution for the treatment of patients with lower extremity fractures and deformities. It expands the company’s offering to 52 unique systems specifically designed to help address the needs of pediatric patients. The PNP tibial system features rigid cannulated nails ranging in diameter from 7 mm to 12 mm and includes specialized instrumentation to facilitate multiple surgical techniques. Like other OrthoPediatrics products, this system is designed for the anatomy of children and growing patients.
The versatility and scope of the PNP Tibia System were on full display in these two surgical cases. One case was a trauma procedure for a 6-foot teenager requiring a large nail (12mm x 420mm), while the other was a deformity correction procedure for a 15-year-old of smaller stature requiring a 7mm x 285mm was used. These two cases reflect that OP has the broadest scope of pediatric-focused cannulated nails in the industry, allowing surgeons to treat children of all sizes and needs.
Joe Hauser, president of OrthoPediatrics Trauma & Deformity Correction, said: “It is extremely gratifying to see the system perform successfully in two unique and challenging cases. It shows that the surgeon’s expert design team together with the OP engineers have achieved a goal in designing a system that will help many children for years to come.”
About OrthoPediatrics Corp.
Founded in 2006, OrthoPediatrics is an orthopedic company focused exclusively on advancing the field of pediatric orthopedics. As such, it has developed the most comprehensive product offering for the pediatric orthopedic market to improve the lives of children with orthopedic conditions. OrthoPediatrics currently markets 52 systems serving three of the largest categories within the pediatric orthopedic market. This product offering includes trauma and deformity, scoliosis and sports medicine/other procedures. OrthoPediatrics’ global sales organization focuses exclusively on pediatric orthopedics and distributes its products in the United States and more than 70 countries outside the United States. For more information, please visit www.orthopediatrics.com.
Contact person for investors
Philip Trip Taylor
Gilmartin Group
philip@gilmartinir.com
415-937-5406
One Comment